We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-15.83%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.76B
AUM Growth
-$3.06B
Cap. Flow
-$2.1B
Cap. Flow %
-55.74%
Top 10 Hldgs %
30.37%
Holding
139
New
24
Increased
31
Reduced
30
Closed
45

Sector Composition

Rank Sector Weight
1 Healthcare 51.45%
2 Technology 16.06%
3 Financials 5.24%
4 Communication Services 3.47%
5 Consumer Discretionary 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
126
DELISTED
Allergan plc
AGN
-689,949
Closed -$131M
WCG
127
DELISTED
Wellcare Health Plans, Inc.
WCG
-121,313
Closed -$38.9M
MDCO
128
DELISTED
Medicines Co
MDCO
-2,561,640
Closed -$76.6M
ALDR
129
DELISTED
Alder Biopharmaceuticals
ALDR
-1,916,664
Closed -$31.9M
ELGX
130
DELISTED
Endologix Inc
ELGX
-740,859
Closed -$14.2M
ECYT
131
DELISTED
Endocyte, Inc. Common Stock
ECYT
-234,378
Closed -$4.16M
IVTY
132
DELISTED
Invuity, Inc
IVTY
-1,360,334
Closed -$10.1M
RHT
133
DELISTED
Red Hat Inc
RHT
-388,407
Closed -$52.9M

Similar funds

PFM Health Sciences's Q4 2018 Portfolio in Review

As of Q4 2018, PFM Health Sciences held 139 positions worth $3.76B, down 45% from $6.83B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

PFM Health Sciences withdrew a net $2.1B in Q4 2018, closing 45 positions and reducing 30 holdings. Its most notable exit was Viatris, an estimated $172M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 50% a quarter earlier, followed by Technology and Financials.

Against the trend, PFM Health Sciences opened a new position in Microchip Technology worth $74.3M.

  • PFM Health Sciences's largest Q4 2018 buy was Microchip Technology: 2,064,984 shares worth $74.3M.
  • PFM Health Sciences added most to GoDaddy in Q4 2018, an estimated $74.9M increase.
  • PFM Health Sciences's biggest Q4 2018 reduction was Pacira BioSciences, cutting an estimated $106M.
  • PFM Health Sciences fully exited Viatris in Q4 2018, selling an estimated $172M.
  • PFM Health Sciences's ten largest holdings make up 30% of its $3.76B portfolio in Q4 2018.
  • PFM Health Sciences opened 24 new positions and closed 45 in Q4 2018.
  • PFM Health Sciences's portfolio value fell 45% quarter-over-quarter to $3.76B.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.